Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2023) Oral polio vaccine stockpile modeling: insights from recent experience. Expert Review of Vaccines 22:1, pages 813-825.
Read now
Read now
Hitt Sharma, Sanjay Lalwani, Sameer Parekh, Pramod Pujari, Sunil Shewale, Sonali Palkar, Neeta Hanumante, Shilpa Gokhale, Jaganathan Ks, Rakesh Kumar, Inderjit Sharma & Sunil Gairola. (2022) A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Shuchen Wang, Monica Tafalla, Linda Hanssens & Jan Dolhain. (2017) A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines. Expert Review of Vaccines 16:11, pages 1095-1105.
Read now
Read now
Karen V. Lithgow & Caroline E. Cameron. (2017) Vaccine development for syphilis. Expert Review of Vaccines 16:1, pages 37-44.
Read now
Read now
Lei Ma, Wei Cai, Mingbo Sun, Yina Cun, Jian Zhou, Jing Liu, Wenzhu Hu, Xinwen Zhang, Shaohui Song, Shude Jiang & Guoyang Liao. (2016) Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats. Human Vaccines & Immunotherapeutics 12:12, pages 3125-3131.
Read now
Read now
Edward PK Parker, Natalie A Molodecky, Margarita Pons-Salort, Kathleen M O’Reilly & Nicholas C Grassly. (2015) Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. Expert Review of Vaccines 14:8, pages 1113-1123.
Read now
Read now
Manish Patel, Simona Zipursky, Walt Orenstein, Julie Garon & Michel Zaffran. (2015) Polio endgame: the global introduction of inactivated polio vaccine. Expert Review of Vaccines 14:5, pages 749-762.
Read now
Read now
Matthew J Robbins & Sheldon H Jacobson. (2015) Analytics for vaccine economics and pricing: insights and observations. Expert Review of Vaccines 14:4, pages 605-616.
Read now
Read now
Jessica A White, Jeremy S Blum, Nancy A Hosken, Joshua O Marshak, Lauren Duncan, Changcheng Zhu, Elizabeth B Norton, John D Clements, David M Koelle, Dexiang Chen, William C Weldon, M Steven Oberste & Manjari Lal. (2014) Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system. Human Vaccines & Immunotherapeutics 10:12, pages 3611-3621.
Read now
Read now
Sarah L Sheridan, Katie Frith, Thomas L Snelling, Keith Grimwood, Peter B McIntyre & Stephen B Lambert. (2014) Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Review of Vaccines 13:9, pages 1081-1106.
Read now
Read now
Articles from other publishers (16)
Emmanuel J. Vidor & John F. Modlin. 2023. Plotkin's Vaccines. Plotkin's Vaccines
890
913.e14
.
Janice Seinfeld, María Laura Rosales, Alfredo Sobrevilla & Juan Guillermo López Yescas. (2022) Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru. BMC Health Services Research 22:1.
Crossref
Crossref
S Mangarule, S Palkar, M Mitra, MD Ravi, R Singh, A Moureau, MV Jayanth, DM Patel, S Ravinuthala, BN Patnaik, E Jordanov & F Noriega. (2022) Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India. Vaccine: X, pages 100190.
Crossref
Crossref
S. Mangarule, S. Palkar, M. Mitra, M.D. Ravi, A.P. Dubey, A. Moureau, M.V. Jayanth, D.M. Patel, S. Ravinuthala, S.R. Jagga, B.N. Patnaik, E. Jordanov & F. Noriega. (2022) Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India. Vaccine: X 10, pages 100137.
Crossref
Crossref
Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble & Sathiah Thennarasu. (2021) A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2. RSC Advances 11:33, pages 20006-20035.
Crossref
Crossref
Nishant Sawant, Kawaljit Kaur, David A. Holland, John M. Hickey, Sanjeev Agarwal, Joseph R. Brady, Neil C. Dalvie, Mary Kate Tracey, M. Lourdes Velez-Suberbie, Stephen A. Morris, Shaleem I. Jacob, Daniel G. Bracewell, Tarit K. Mukhopadhyay, Kerry R. Love, J. Christopher Love, Sangeeta B. Joshi & David B. Volkin. (2021) Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens. Journal of Pharmaceutical Sciences 110:3, pages 1042-1053.
Crossref
Crossref
Kawaljit Kaur, Jian Xiong, Nishant Sawant, Sanjeev Agarwal, John M. Hickey, David A. Holland, Tarit K. Mukhopadhyay, Joseph R. Brady, Neil C. Dalvie, Mary Kate Tracey, Kerry R. Love, J. Christopher Love, David D. Weis, Sangeeta B. Joshi & David B. Volkin. (2021) Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine. Journal of Pharmaceutical Sciences 110:3, pages 1054-1066.
Crossref
Crossref
Alex-Mikael Barkoff & Qiushui He. 2019. Pertussis Infection and Vaccines. Pertussis Infection and Vaccines
19
33
.
Emmanuel Vidor. 2018. Plotkin's Vaccines. Plotkin's Vaccines
841
865.e10
.
Michael D. Decker, Kathryn M. Edwards & Barbara J. Howe. 2018. Plotkin's Vaccines. Plotkin's Vaccines
198
227.e13
.
A. Shashidhar. (2017) Hexavalent vaccinations: The future of routine immunization?. Indian Pediatrics 54:1, pages 11-13.
Crossref
Crossref
Heleen Kraan, Rimko ten Have, Larissa van der Maas, Gideon Kersten & Jean-Pierre Amorij. (2016) Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine. Vaccine 34:38, pages 4572-4578.
Crossref
Crossref
Alex-Mikael Barkoff, Kirsi Gröndahl-Yli-Hannuksela & Qiushui He. (2015) Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathogens and Disease 73:7, pages ftv050.
Crossref
Crossref
Zeinab Nabil Ahmed Said. (2015) Induced immunity against hepatitis B virus. World Journal of Hepatology 7:12, pages 1660.
Crossref
Crossref
Ana Marli Christovam Sartori, Margarete Paganotti Vicentine, Lígia Castelloni Figueiredo Gryninger, Patricia Coelho de Soárez & Hillegonda Maria Dutilh Novaes. (2015) Polio inactivated vaccine costs into routine childhood immunization in Brazil. Revista de Saúde Pública 49:0.
Crossref
Crossref
Barbara Sanders, Martin Koldijk & Hanneke Schuitemaker. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control
45
80
.